Stockholders’ Equity and Equity-Based Compensation | Stockholders’ Equity and Equity-Based Compensation Stockholders’ Equity Common Stock The Company issued approximately 163,000 and 126,000 shares of common stock during the three months ended June 30, 2021 and 2020, respectively, and 370,000 and 190,000 for the six months ended June 30, 2021 and 2020, respectively, related to the exercise of stock options and the vesting of Restricted Stock Units. Treasury Stock In October 2015, the Company’s Board of Directors approved a share repurchase program, authorizing the Company to purchase up to $100 million of its common stock. In February 2017, the Company’s Board of Directors approved an increase to the share repurchase program, authorizing the Company to repurchase up to an additional $100 million of its outstanding common stock. During the six months ended June 30, 2021 and 2020, the Company did not repurchase any shares of its common stock under the share repurchase program. As of June 30, 2021, the Company had $100 million of remaining authorization for purchases under the share repurchase program. The Company expects to fund future repurchases, if any, through a combination of cash on hand, cash generated by operations and future financing transactions, if appropriate. Accordingly, the share repurchase program is subject to the Company having available cash to fund repurchases. Under the share repurchase program, management is authorized to purchase shares of the Company’s common stock from time to time through open market purchases or privately negotiated transactions at prevailing prices as permitted by securities laws and other legal requirements, and subject to market conditions and other factors. Dividends The Company declared and paid cash dividends of $0.21 and $0.42 per share of common stock, or $7.7 million and $15.3 million, during the three and six months ended June 30, 2021, respectively, and $0.17 and $0.34 per share of common stock, or $6.1 million and $12.1 million, during the three and six months ended June 30, 2020, respectively. On July 19, 2021, the Company’s Board of Directors declared a quarterly cash dividend of $0.21 per share of outstanding common stock payable on September 16, 2021 to stockholders of record at the close of business on September 2, 2021. Future declarations of dividends are subject to the final determination of the Board of Directors, and will depend on, among other things, the Company’s future financial condition, results of operations, capital requirements, capital expenditure requirements, contractual restrictions, anticipated cash needs, business prospects, provisions of applicable law and other factors the Board of Directors may deem relevant. Equity-Based Compensation The Company recognizes stock-based compensation expense for all equity-based payment awards, including employee Restricted Stock Units and Performance-based Restricted Stock Units (“PRSUs” and, collectively with Restricted Stock Units, “RSUs”) and stock options granted under the Company’s Amended and Restated 2012 Omnibus Equity Incentive Plan (the “2012 Plan”), based on the fair value of each award on the grant date. The following table summarizes non-cash equity-based compensation expense, net of forfeitures, by financial statement line item included in the accompanying Consolidated Statements of Operations for the three and six months ended June 30, 2021 and 2020 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Cost of revenue $ 194 $ 99 $ 358 $ 150 Sales and marketing 926 374 1,393 834 Product development 1,799 1,068 3,028 2,193 General and administrative 6,767 2,095 13,117 6,219 Total $ 9,686 $ 3,636 $ 17,896 $ 9,396 The following table summarizes non-cash equity-based compensation expense, net of forfeitures, by award type included in the accompanying Consolidated Statements of Operations for the three and six months ended June 30, 2021 and 2020 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Stock options $ 177 $ 414 $ 352 $ 1,730 RSUs 9,509 3,222 17,544 7,666 Total $ 9,686 $ 3,636 $ 17,896 $ 9,396 Stock Option Awards During the six months ended June 30, 2021, no options to purchase shares of its common stock were granted. As of June 30, 2021, there were approximately 300,000 options vested and exercisable with a weighted average exercise price of $34.43. As of June 30, 2021, the total unrecognized compensation charge related to non-vested options was approximately $1.3 million, which is expected to be recognized through 2023. Restricted Stock Unit Awards During the six months ended June 30, 2021, the Company had RSU grants, net of forfeitures, of approximately 382,000. As of June 30, 2021, there are approximately 1,242,000 non-vested RSUs outstanding with a weighted average grant-date fair value of $56.89. As of June 30, 2021, the total unrecognized non-cash equity-based compensation charge related to the non-vested RSUs was approximately $56.7 million, which is expected to be recognized through 2024. |